These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2170490)

  • 1. Evidence that bremazocine prevents urine retention induced by intraspinal cord injection of colchicine in rats.
    Zanoli P; Baraldi M
    J Auton Nerv Syst; 1990 Jul; 30 Suppl():S191-3. PubMed ID: 2170490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of colchicine on micturition reflex in rats.
    Zanoli P; Ferrari W
    Neurotoxicol Teratol; 1988; 10(6):579-84. PubMed ID: 3244348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine retention due to intra-spinal cord injection of colchicine in rats: improved recovery of bladder function by monosialoganglioside GM1 and nerve growth factor administration.
    Baraldi M; Zanoli P; Truzzi C; Paro M; Italiano G; Prosdocimi M
    Funct Neurol; 1991; 6(3):235-8. PubMed ID: 1743534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermorphin inhibits micturition reflex in rats at a central site of action.
    Maggi CA; Giuliani S; Meli A
    J Auton Nerv Syst; 1989 Feb; 26(1):11-6. PubMed ID: 2540230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of peripheral and spinal endothelin receptors in the micturition reflex in rats.
    Ogawa T; Kamo I; Pflug BR; Nelson JB; Seki S; Igawa Y; Nishizawa O; de Groat WC; Chancellor MB; Yoshimura N
    J Urol; 2004 Oct; 172(4 Pt 1):1533-7. PubMed ID: 15371886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa-opioid receptor stimulation abolishes mu- but not delta-mediated inhibitory control of spinal Met-enkephalin release.
    Collin E; Bourgoin S; Ferhat L; Hamon M; Cesselin F
    Neurosci Lett; 1992 Jan; 134(2):238-42. PubMed ID: 1317026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
    Parsons CG; West DC; Headley PM
    NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplicity of kappa opioid receptor binding in the rat cardiac sarcolemma.
    Zhang WM; Jin WQ; Wong TM
    J Mol Cell Cardiol; 1996 Jul; 28(7):1547-54. PubMed ID: 8841942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative kappa-2 opioid agonists are antihyperalgesic in a rat model of inflammation.
    Ho J; Mannes AJ; Dubner R; Caudle RM
    J Pharmacol Exp Ther; 1997 Apr; 281(1):136-41. PubMed ID: 9103490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J; Kendig JJ
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
    Devlin T; Shoemaker WJ
    J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of mu and kappa opioid systems on motivational processes.
    Shippenberg TS; Herz A
    NIDA Res Monogr; 1986; 75():563-66. PubMed ID: 2829003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal opioid receptors and inhibition of urinary bladder motility in vivo.
    Dray A; Metsch R
    Neurosci Lett; 1984 Jun; 47(1):81-4. PubMed ID: 6087220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal kappa-opioid receptor-mediated antinociception is stimulus-specific.
    Schmauss C
    Eur J Pharmacol; 1987 Jun; 137(2-3):197-205. PubMed ID: 2886350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the respiratory depressant and analgesic effects of bremazocine, a kappa-agonist.
    Pazos A; Tristán C; Flórez J
    Life Sci; 1983; 33 Suppl 1():579-81. PubMed ID: 6319913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG; West DC; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
    Horan PJ; de Costa BR; Rice K; Haaseth RC; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1993 Aug; 266(2):926-33. PubMed ID: 8394923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266.
    Frey HH
    Pharmacol Toxicol; 1988 Mar; 62(3):150-4. PubMed ID: 2836842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice.
    Horan P; de Costa BR; Rice KC; Porreca F
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1154-61. PubMed ID: 1646325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.